Loading…
ENDRA Life Sciences Inc. is projected to rise to $5.74 by 2027, a +37% move from its current price of $4.18. NDRA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $3.94 | $4.18 | $4.43 | -0.05% |
| Aug 6 | $3.84 | $4.18 | $4.54 | -0.09% |
| Aug 7 | $3.77 | $4.17 | $4.62 | -0.14% |
| Aug 8 | $3.71 | $4.17 | $4.69 | -0.18% |
| Aug 9 | $3.66 | $4.17 | $4.76 | -0.23% |
| Aug 10 | $3.61 | $4.17 | $4.81 | -0.27% |
| Aug 11 | $3.57 | $4.17 | $4.87 | -0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.57 | $4.17 | $4.87 | -0.32% |
| Week 2 | $3.33 | $4.15 | $5.18 | -0.64% |
| Week 3 | $3.16 | $4.14 | $5.42 | -0.96% |
| Week 4 | $3.02 | $4.13 | $5.63 | -1.27% |
| Week 5 | $2.91 | $4.11 | $5.82 | -1.59% |
| Week 6 | $2.80 | $4.10 | $6.00 | -1.91% |
| Week 7 | $2.71 | $4.09 | $6.17 | -2.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis.
ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan. It is categorized under Healthcare.
ENDRA Life Sciences Inc. (NDRA) is currently trading at $4.46 with a market capitalization of $5.66M and a rank of 5014.
The 30-day technical picture shows neutral sentiment, with RSI14 at 50. The 50-day simple moving average is $5.11 and the 200-day simple moving average is $4.93.
Key near-term levels are a support at $4.30 and a resistance at $6.27, while the 30-day range runs from $2.92 to $6.82.
Annualized volatility is 100%.
Forecast highlights show a bullish trajectory beginning in 2027, with the avg price rising from $4.46 in 2026 to $20.89 in 2050 and ROIs reaching as high as 368.3% in 2050.
A major floor 25.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.9% away) — a key level to hold.
The nearest ceiling, 50.0% above — a clean break opens room to run.
A major ceiling 68.9% above — clearing it would confirm fresh momentum.
Key NDRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NDRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.54 | Sell | $4.62 | Sell |
| MA 10 | $4.87 | Sell | $4.78 | Sell |
| MA 20 | $5.06 | Sell | $4.93 | Sell |
| MA 50 | $5.02 | Sell | $4.98 | Sell |
| MA 100 | $4.85 | Sell | $4.94 | Sell |
| MA 200 | $4.88 | Sell | $14.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.10 | Neutral |
| Stoch RSI (14) | 37.34 | Neutral |
| CCI (20) | -65.82 | Neutral |
| Williams %R (14) | -71.09 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -16.22 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 28.91 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.49 | Sell |
| Ultimate (7,14,28) | 30.17 | Neutral |
| Momentum (10) | -0.29 | Sell |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 4.28 | Sell |
| ADX (14) | 10.01 | Neutral |
| ATR (14) | 0.26 | Info |
The near-term picture is neutral, with RSI 14 at 50. The price context shows the SMA50 at $5.11 and the SMA200 at $4.93.
Near-term support sits at $4.30 and resistance at $6.27. The 30-day price range spans from $2.92 to $6.82, indicating potential for upside and downside within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.26 | $4.18 | $5.73 | 0% | Neutral | |
| $4.19 | $5.74 | $8.52 | +37% | Bullish | |
| $4.56 | $6.66 | $10.53 | +59% | Bullish | |
| $4.47 | $6.87 | $11.42 | +64% | Bullish | |
| $4.13 | $6.66 | $11.53 | +59% | Bullish | |
| $3.37 | $5.68 | $10.18 | +36% | Bullish | |
| $3.52 | $6.18 | $11.43 | +48% | Bullish | |
| $4.46 | $8.17 | $15.53 | +95% | Bullish | |
| $5.22 | $9.95 | $19.39 | +138% | Bullish | |
| $5.12 | $10.14 | $20.22 | +143% | Bullish | |
| $6.38 | $14.17 | $31.08 | +239% | Bullish | |
| $8.32 | $18.48 | $42.51 | +342% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.26 | $4.18 | $5.25 | +0.00% |
| September 2026 | $3.27 | $3.98 | $5.04 | -4.87% |
| October 2026 | $3.25 | $4.01 | $5.19 | +0.82% |
| November 2026 | $3.51 | $4.37 | $5.75 | +9.05% |
| December 2026 | $3.41 | $4.29 | $5.73 | -1.77% |
Click any year to see its month-by-month NDRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
ENDRA Life Sciences Inc.'s 2026 outlook centres on $4.18, within a $3.26 to $5.73 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, NDRA could reach as high as $8.52, with a base case around $5.74 and support toward $4.19 — roughly +37% from $4.18. Buyers look set to stay in control over this stretch.
Expect NDRA to range from $4.56 to $10.53 through 2028. The $6.66 average target implies a +59% move from current prices. That is up +16% on the projected 2027 average. Momentum favours further upside here.
The NDRA price prediction for 2029 points to an average of $6.87 (low $4.47, high $11.42) — a potential gain of +64% on today's $4.18. Buyers look set to stay in control over this stretch.
In 2030, NDRA is projected to trade between $4.13 and $11.53, averaging $6.66 — a potential gain of +59% from today's $4.18. That is -3% versus the projected 2029 average. Momentum favours further upside here.
ENDRA Life Sciences Inc.'s 2031 outlook centres on $5.68, within a $3.37 to $10.18 range. That is -15% versus the projected 2030 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, NDRA could reach as high as $11.43, with a base case around $6.18 and support toward $3.52 — roughly +48% from $4.18. Momentum favours further upside here.
Expect NDRA to range from $4.46 to $15.53 through 2033. The $8.17 average target implies a +95% move from current prices. That is up +32% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The NDRA price prediction for 2034 points to an average of $9.95 (low $5.22, high $19.39) — a potential gain of +138% on today's $4.18. Momentum favours further upside here.
In 2035, NDRA is projected to trade between $5.12 and $20.22, averaging $10.14 — a potential gain of +143% from today's $4.18. That is up +2% on the projected 2034 average. Buyers look set to stay in control over this stretch.
ENDRA Life Sciences Inc.'s 2040 outlook centres on $14.17, within a $6.38 to $31.08 range. That is up +40% on the projected 2035 average. That marks a +239% change versus current levels. Momentum favours further upside here.
By 2050, NDRA could reach as high as $42.51, with a base case around $18.48 and support toward $8.32 — roughly +342% from $4.18. Buyers look set to stay in control over this stretch.
Investing $1,000 in NDRA today (≈ 239.23445 NDRA) could be worth
$4,421.54
+$3,421.54 (+342%) by 2050 · US Dollar
Based on the average projected NDRA price of $18.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NDRAwould be worth at today's price.
$1,000 invested in NDRA on Jul 31, 2025 (≈ 189.393932 NDRA) would be worth
$791.67
-$208.33 (-20.8%) today · 0.79× · US Dollar
Based on a NDRA entry price of $5.28 vs. today's $4.18.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.86 | $860.08 | -14.0% |
| 1 month ago | $5.04 | $829.37 | -17.1% |
| 3 months ago | $4.95 | $844.44 | -15.6% |
| 6 months ago | $3.58 | $1,167.6 | +16.8% |
| 1 year ago | $5.28 | $791.67 | -20.8% |
| All time (5.0y) ago | $64,400 | $0.06 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NDRA forecast.
Our base-case forecast reaches $8.40 around 2034.
Implied market cap at $8.40: $10.67M
The multi-year forecast shows a bullish trend starting in 2027. In 2026, the min is $3.26, the avg is $4.46 and the max is $6.08, with ROI 0 and sentiment NEUTRAL.
From 2027 through 2032, the averages rise from $6.29 to $6.76, with ROIs of 41% to 51.6% and a bullish sentiment.
In 2033, the avg is $9.30 (max $17.69, ROI 108.6%); 2034 shows avg $11.08 (max $21.61, ROI 148.5%); 2035 shows avg $11.02 (max $22.00, ROI 147.2%), all with BULLISH sentiment.
Longer-horizon levels show strong upside: 2040 avg $15.96 (max $35.02, ROI 257.9%), and 2050 avg $20.89 (max $48.04, ROI 368.3%), with sentiment remaining BULLISH.
Tap a question to reveal the answer.
Avg $7.28; max $12.61; min $4.51; ROI 63.2%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with avg price rising to $20.89 by 2050 and ROI 368.3% by 2050; these are estimates and not guarantees.
2033 avg $9.30 and 2034 avg $11.08, with higher potential max values (2033 max $17.69; 2034 max $21.61) indicating feasibility of surpassing $10.
Current price $4.46 and market cap $5.66M.
The 30-day range is $2.92 to $6.82 and annualized volatility is 100%, indicating notable near-term variability.
ENDRA Life Sciences Inc. Community Discussion
0Share your ENDRA Life Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.